Dystonia-plus syndromes

European Journal of Neurology

Volumn 17, Issue SUPPL. 1, 2010, Pages 37-45

  Asmus, F ^a,b   Gasser, T ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Dopa responsive dystonia; Dystonia plus syndromes; Gene; Myoclonus dystonia; Rapid onset dystonia parkinsonism; RDP

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; PROTEIN SUBUNIT; SEPIAPTERIN REDUCTASE; TYROSINE 3 MONOOXYGENASE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1A3 PROTEIN, HUMAN; CHAPERONE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; SARCOGLYCAN; TOR1A PROTEIN, HUMAN;

ADULT; AUTOSOMAL DOMINANT INHERITANCE; AUTOSOMAL RECESSIVE DISORDER; CEREBROSPINAL FLUID; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPAMINE RESPONSIVE DYSTONIA; DRUG EFFICACY; DYSTONIA; DYSTONIA PLUS SYNDROME; GENE MUTATION; HUMAN; MYOCLONUS DYSTONIA; NEUROLOGIC DISEASE; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; RAPID ONSET DYSTONIA PARKINSONISM; TREATMENT RESPONSE; CLASSIFICATION; COMPLICATION; DEFICIENCY; GENETIC SCREENING; GENETICS; HETEROZYGOTE; MUTATION; ONSET AGE; PARKINSONIAN DISORDERS; SYNDROME;

AGE OF ONSET; DIAGNOSIS, DIFFERENTIAL; DYSTONIA; GENETIC TESTING; GTP CYCLOHYDROLASE; HETEROZYGOTE; HUMANS; MOLECULAR CHAPERONES; MUTATION; PARKINSONIAN DISORDERS; SARCOGLYCANS; SODIUM-POTASSIUM-EXCHANGING ATPASE; SYNDROME; TYROSINE 3-MONOOXYGENASE;

EID: 77953350186     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2010.03049.x     Document Type: Conference Paper

References (32)

1. Nygaard TG, Marsden CD, Duvoisin RC. Dopa-responsive dystonia. Adv Neurol 1988 50 : 377 384.
2. Segawa M, Nomura Y, Nishiyama N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003 54 (Suppl. 6 S32 S45.
3. Chieng KS, Hussain N, Gosalakkal JA. Dystonia during feeding as an early sign of dopa-responsive dystonia. Pediatr Neurol 2007 37 : 215 217.
4. Trender-Gerhard I, Sweeney MG, Schwingenschuh P, et al. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry 2009 80 : 839 845.
5. Tassin J, Durr A, Bonnet A-M, et al. Levodopa-responsive dystonia: GTP cyclohydrolase I or parkin mutations? Brain 2000 123 : 1112 1121.
6. Asmus F, Langseth A, Doherty E, et al. "Jerky" dystonia in children: spectrum of phenotypes and genetic testing. Mov Disord 2009 24 : 702 709.
7. Thony B, Blau N. Mutations in the BH(4)-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a-dehydratase, and dihydropteridine reductase. Hum Mutat 2006 27 : 870 878.
8. Wider C, Melquist S, Hauf M, et al. Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1: redefining DYT14 as DYT5. Neurology. 2008 70 : 1377 1383.
9. Sato K, Sumi-Ichinose C, Kaji R, et al. Differential involvement of striosome and matrix dopamine systems in a transgenic model of dopa-responsive dystonia. Proc Natl Acad Sci U S A 2008 105 : 12551 12556.
10. Rajput AH, Gibb WR, Zhong XH, et al. Dopa-responsive dystonia: pathological and biochemical observations in a case. Ann Neurol 1994 35 : 396 402.
11. Goto S, Lee LV, Munoz EL, et al. Functional anatomy of the basal ganglia in X-linked recessive dystonia-parkinsonism. Ann Neurol 2005 58 : 7 17.
12. Furukawa Y. Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss. Adv Neurol 2003 91 : 401 410.
13. Bandmann O, Goertz M, Zschocke J, et al. The phenylalanine loading test in the differential diagnosis of dystonia. Neurology 2003 60 : 700 702.
14. Snow BJ, Nygaard TG, Takahashi H, Calne DB. Positron emission tomographic studies of dopa-responsive dystonia and early-onset idiopathic parkinsonism. Ann Neurol 1993 34 : 733 738.
15. Jeon BS, Jeong JM, Park SS, et al. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia. Ann Neurol 1998 43 : 792 800.
16. Gasser T. Inherited myoclonus-dystonia syndrome. Adv Neurol 1998 78 : 325 334.
17. Asmus F, Zimprich A, Tezenas Du Montcel S, et al. Myoclonus-dystonia syndrome: epsilon-sarcoglycan mutations and phenotype. Ann Neurol 2002 52 : 489 492.
18. Asmus F, Devlin A, Munz M, Zimprich A, Gasser T, Chinnery PF. Clinical differentiation of genetically proven benign hereditary chorea and myoclonus-dystonia. Mov Disord 2007 22 : 2104 2109.
19. Zimprich A, Grabowski M, Asmus F, et al. Mutations in the gene encoding epsilon-sarcoglycan cause myoclonus-dystonia syndrome. Nat Genet 2001 29 : 66 69.
20. Kinugawa K, Vidailhet M, Clot F, Apartis E, Grabli D, Roze E. Myoclonus-dystonia: An update. Mov Disord 2008 24 : 479 489.
21. Grabowski M, Zimprich A, Lorenz-Depiereux B, et al. The epsilon-sarcoglycan gene (SGCE), mutated in myoclonus-dystonia syndrome, is maternally imprinted. Eur J Hum Genet 2003 11 : 138 144.
22. Asmus F, Hjermind LE, Dupont E, et al. Genomic deletion size at the epsilon-sarcoglycan locus determines the clinical phenotype. Brain 2007 130 : 2736 2745.
23. Roze E, Apartis E, Clot F, et al. Myoclonus-dystonia: clinical and electrophysiologic pattern related to SGCE mutations. Neurology 2008 70 : 1010 1016.
24. Luciano MS, Ozelius L, Sims K, Raymond D, Liu L, Saunders-Pullman R. Responsiveness to levodopa in epsilon-sarcoglycan deletions. Mov Disord 2009 24 : 425 428.
25. de Carvalho Aguiar P, Sweadner KJ, Penniston JT, et al. Mutations in the Na+/K+ -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 2004 43 : 169 175.
26. Kamm C, Fogel W, Wachter T, et al. Novel ATP1A3 mutation in a sporadic RDP patient with minimal benefit from deep brain stimulation. Neurology 2008 70 : 1501 1503.
27. Blanco-Arias P, Einholm AP, Mamsa H, et al. A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. Hum Mol Genet 2009 18 : 2370 2377.
28. Brashear A, Dobyns WB, de Carvalho Aguiar P, et al. The phenotypic spectrum of rapid-onset dystonia-parkinsonism (RDP) and mutations in the ATP1A3 gene. Brain 2007 130 : 828 835.
29. Brashear A, Mulholland GK, Zheng QH, Farlow MR, Siemers ER, Hutchins GD. PET imaging of the pre-synaptic dopamine uptake sites in rapid-onset dystonia-parkinsonism (RDP). Mov Disord 1999 14 : 132 137.
30. Zanotti-Fregonara P, Vidailhet M, Kas A, et al. [123I]-FP-CIT and [99mTc]-HMPAO single photon emission computed tomography in a new sporadic case of rapid-onset dystonia-parkinsonism. J Neurol Sci 2008 273 : 148 151.
31. Deutschlander A, Asmus F, Gasser T, Steude U, Botzel K. Sporadic rapid-onset dystonia-parkinsonism syndrome: failure of bilateral pallidal stimulation. Mov Disord 2005 20 : 254 257.
32. Camargos S, Scholz S, Simon-Sanchez J, et al. DYT16, a novel young-onset dystonia-parkinsonism disorder: identification of a segregating mutation in the stress-response protein PRKRA. Lancet Neurol 2008 7 : 207 215.